Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac

Pathobiology

Volumn 73, Issue 6, 2007, Pages 317-324

  Yamamoto, Kazuhiko ^a   Kitayama, Wakashi ^a   Denda, Ayumi ^a   Sasahira, Tomonori ^a   Kuniyasu, Hiroki ^a   Kirita, Tadaaki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

4 Nitroquinoline 1 oxide (4 NQO); Chemoprevention; Cyclooxygenase 2; Etodolac; Receptor for advanced glycation end products; Tongue carcinogenesis, rat

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; DOWN REGULATION; DRUG MECHANISM; DYSPLASIA; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STATISTICAL SIGNIFICANCE; TONGUE CARCINOMA; TREATMENT DURATION;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTICARCINOGENIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETODOLAC; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MALE; QUINOLONES; RATS; RATS, INBRED F344; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TONGUE; TONGUE NEOPLASMS;

RATTUS;

EID: 33947608917     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099127     Document Type: Article

References (24)

1. Lalla E, Lamster IB, Schmidt AM: Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes. Ann Periodontol 1998;3:13-19.
2. Schmidt AM, Yan SD, Yan SF, Stern DM: The biology of the receptor for advanced glycation end products and its ligands. Biochem Biopyhs Acta 2000;1498:99-111.
3. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kurokawa K, Ito R, Yokozaki H, Yasui W: Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002;196:163-170.
4. Kuniyasu H, Chihara Y, Takahashi T: Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep 2003;10:445-448.
5. Bhawal UK, Ozaki Y, Nishimura M, Sugiyama M, Sasahira T, Nomura Y, Sato F, Fujimoto K, Sasaki N, Ikeda M, Tsuji K, Kuniyasu H, Kato Y: Association of expression of receptor for advanced end products and invasive activity of oral squamous cell carcinoma. Oncology 2005;69:246-255.
6. Shiotani H, Denda A, Yamamoto K, Kitayama W, Endoh T, Sasaki Y, Tsutsumi M, Sugimura M, Konishi Y: Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline 1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. Cancer Res 2001;61:1451-1456.
7. Yamamoto K, Kitayama W, Denda A, Morisaki A, Kuniyasu H, Kirita T: Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas in the tongue of rats initiated by 4-nitoroquinoline 1-oxide. Cancer Lett 2003;199:121-129.
8. Yamamoto K, Kitayama W, Denda A, Morisaki A, Kuniyasu H, Inoue M, Kirita T: Suppressive effect of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Exp Toxicol Pathol 2004;56:145-151.
9. Shanmugan N, Kim YS, Lanting L, Natarajan R: Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem 2003;278:34834-34844.
10. Telser A, Farbman AI, Chacko C: A low-molecular-weight soluble protein from bovine lingual epithelium. II. Purification and characterization. J Invest Dermatol 1982;79:286-292.
11. Koslowski R, Barth K, Augstein A, Tschernig T, Bargsten G, Aufderheide M, Kasper M: A new rat type l-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression. Histochem Cell Biol 2004;121:509-519.
12. 3H]L-NG-nitroarginine binding after transient focal ischemia and NMDA-induced excitotoxicity in type I and type III nitric oxide synthase null mice. J Cereb Blood Flow Metab 1997;7:515-526.
13. Suzuki R, Kohno H, Sugie S, Tanaka T: Dietary protocatechuric acid during the progression phase exerts chemopreventive effects on chemically induced rat tongue carcinogenesis. Asian Pac J Cancer Prev 2003;4:319-326.
14. Ishiguro H, Nakaigawa N, Miyoshi Y, Fujimani K, Kubota Y, Uemura H: Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin, are overexpressed and associated with prostate cancer development. Prostate 2005;64:92-100.
15. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H: The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 2000;275:25781-25790.
16. Li J, Qu X, Schmidt AM: Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J Biol Chem 1998;273:30870-30878.
17. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manoque KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
18. Czura CJ, Wang H, Tracey KJ: Dual roles for HMGB1: DNA binding and cytokine. J Endotoxin Res 2001;7:315-321.
19. Thornalley PJ: Cell activation by glycerated proteins, AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 1998;44:1013-1023.
20. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM: Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastasis. Nature 2000;405:354-360.
21. Rojas A, Caveda L, Romay C, Lópes E, Valdés S, Padrón J, Glacia L, Martinez O, Delgado R: Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages. Biochem Biophys Res Commun 1996;225:358-362.
22. Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptors but different downstream signaling pathways. J Biol Chem 1999;274:19919-19924.
23. Huttunen HJ, Kuja-Panula J, Sorei G, Agneletti AL, Donato R, Rauvala H: Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000;275:40096-40105.
24. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H: Advanced glycation end products-driven angiogenesis in vitro: Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 1997;272:8723-8730.